Oral vaccine against ruminant respiratory disease comprising polyvinylpyrrolidone
The present invention relates to an oral vaccine against respiratory disease in ruminants, comprising live attenuated Mannheimia haemolytica bacteria and a Polyvinylpyrrolidone (PVP). The addition of PVP significantly improves the protective effect of vaccination on lung scores after a challenge inf...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
30.05.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to an oral vaccine against respiratory disease in ruminants, comprising live attenuated Mannheimia haemolytica bacteria and a Polyvinylpyrrolidone (PVP). The addition of PVP significantly improves the protective effect of vaccination on lung scores after a challenge infection. Further the PVP allows vaccination by a method of mass administration, such as by oral route via a drink. In addition the invention relates to methods for the preparation of such a vaccine, to methods for the vaccination of ruminants employing such a vaccine, and to medical uses of a composition comprising M. haemolytica bacteria. |
---|---|
Bibliography: | Application Number: AU20170375720 |